IPO round-up: KineMed pulls plans; Intersect prices at low end
This article was originally published in Clinica
Executive Summary
The medtech IPO market seems to be picking up, but we may not be out of the woods just yet. There has been a rash of companies launching on the public markets recently, but not all have seen their offering through. One such firm is diagnostic specialist KineMed, which has withdrawn its plans for a $32m IPO.